The Status and Influencing Factors of COVID-19 Vaccination for 3–7-Year-Old Children Born Prematurely
Jingyun Shi,Fangping Zhao,Wanyin Yang,Yuru Zhu,Min Wang,Bin Yi
DOI: https://doi.org/10.2147/ppa.s451654
2024-03-30
Patient Preference and Adherence
Abstract:Jingyun Shi, 1, &ast Fangping Zhao, 1, &ast Wanyin Yang, 2 Yuru Zhu, 1 Min Wang, 1 Bin Yi 1 1 Department of NICU, Gansu Provincial Maternal and Child Care Hospital (Gansu Provincial Central Hospital), Lanzhou City, Gansu, 730050, People's Republic of China; 2 Department of NICU, Gansu University of Chinese Medicine, Lanzhou City, Gansu, 730050, People's Republic of China &astThese authors contributed equally to this work Correspondence: Min Wang; Bin Yi, Department of NICU, Gansu Provincial Maternal and Child care Hospital (Gansu Provincial Central Hospital), No. 143 of Qilihe North Street, Qilihe District, Lanzhou, 730050, People's Republic of China, Tel +86 13919819662, Email ; Objective: To explore the status and influencing factors of COVID-19 vaccination for 3– 7-year-old children born prematurely. Methods: A questionnaire was administered to parents of preterm infants born between 1 January 2016 and 31 December 2019 in Gansu Maternal and Child Health Hospital using convenience sampling. Results: It was found that 96.81% of 282 parents had known about COVID-19 vaccines and acquired COVID-19- and vaccine-related knowledge primarily through WeChat (104/282, 36.88%) and TikTok (91/282, 32.27%). Most parents of the group whose children were vaccinated with a COVID-19 vaccine believed that this approach was effective in preventing COVID-19 (49.75%), whereas most parents of the group whose children were not vaccinated were worried about the adverse reaction and safety of the vaccine (45.88%). According to the regression analysis, the risk factors of children born prematurely receiving a COVID-19 vaccine were no vaccination against COVID-19 in the mothers (odds ratio [ OR ]=48.489, 95% CI : 6.524– 360.406) and in younger children ( OR =12.157, 95% CI : 6.388– 23.139). Previous history of referral ( OR =0.229, 95% CI : 0.057– 0.920), history of diseases ( OR =0.130, 95% CI : 0.034– 0.503) and high educational level of guardians ( OR =0.142, 95% CI : 0.112– 0.557) were protective factors for children born prematurely to receive COVID-19 vaccination. Conclusion: There is a relatively high proportion of children born prematurely receiving COVID-19 vaccination, but some people still have concerns. Publicity in the later stage can be conducted through WeChat, TikTok and other social media platforms, with special attention paid to the populations with lower education levels. Keywords: COVID-19 vaccine, vaccination willingness, children born prematurely, influencing factors In 2019, an outbreak of unexplained pneumonia occurred in Wuhan, Hubei Province, China. Epidemiological surveys revealed that this cluster of cases was linked to the nearby South China Seafood Market. 1,2 The World Health Organization (WHO) further confirmed that the pandemic of this acute respiratory infectious disease was caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). 3 The SARS-CoV-2 virus is highly contagious and can be rapidly transmitted through the respiratory tract, resulting in the global COVID-19 pandemic. 4 As of 13 May 2021, approximately 160 million people in 223 countries/regions worldwide have been infected with SARS-CoV-2, leading to over 3.32 million deaths due to severe COVID-19 complications. 5 Although this infection is less common in children than in adults, there are still reports of confirmed cases of children with COVID-19. 6 According to the report by SHAH, 7 children with COVID-19 accounted for one tenth of the total cases of COVID-19 in the United States, and corresponding deaths for 3.31% of the total deaths from this infectious disease. The COVID-19 vaccine is a vaccine against SARS-CoV-2, and COVID-19 vaccination is the most effective means to prevent and control the pandemic. 8 Moreover, successive marketing and orderly COVID-19 vaccinations are conducive to effective control of the COVID-19 pandemic in China. However, the COVID-19 vaccine is a newly developed product in a special period, with a limited total temporal span from research and development to marketing of less than one year. With the gradual increase in the number of vaccine recipients, some unexpected rare and serious adverse events emerged, such as thromboembolism caused by the AstraZeneca AZD1222 and Johnson & Johnson vaccines for COVID-19. 9 In addition, the use of a new generation of mRNA-based vaccines is unprecedented among the different types of COVID-19 vaccines, and the immune response to vaccines is importantly correlated with the age, sex and disease o -Abstract Truncated-
medicine, general & internal